ChromaDex【CDXC】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

6.705

買値

6.70

売値

6.71

出来高

490,092

6.60 日の範囲 7.02

1.32 52 週間の範囲 7.9738

時価総額

512.15M

前日終値

6.66

始値

6.88

時刻

6.7

最終取引時間

05:28:46

財務取引量

US$ 3,303,844

VWAP

6.7413

平均取引量 (3 か月)

1,254,363

発行済株式数

76,383,267

配当利回り

PER

-103.25

1 株当たり利益 (EPS)

-0.06

歳入

83.57M

純利益

-4.94M

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. 詳細を表示

セクター

Medicinal Chems,botanicl Pds

業界

Medicinal Chems,botanicl Pds

ウェブサイト

www.chromadex.com

本社

Dover, Delaware, USA

設立

ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the ナスダック市場 with ticker CDXC. The last closing price for ChromaDex was US$6.66. Over the last year, ChromaDex shares have traded in a share price range of US$ 1.32 to US$ 7.9738.

ChromaDex currently has 76,383,267 shares in issue. The market capitalisation of ChromaDex is US$508.71 million. ChromaDex has a price to earnings ratio (PE ratio) of -103.25.

Form 8-K - Current report

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.8906	-11.7252093317	7.5956	7.9738	6.6	715465	7.25565316	CS
4	0.025	0.374251497006	6.68	7.9738	6.22	969606	7.25278538	CS
12	3.205	91.5714285714	3.5	7.9738	3.18	1254363	5.95071518	CS
26	3.805	131.206896552	2.9	7.9738	2.305	788912	5.1600507	CS
52	5.285	372.183098592	1.42	7.9738	1.32	509739	4.68679916	CS
156	2.345	53.7844036697	4.36	7.9738	1.15	346218	3.35739661	CS
260	2.915	76.9129287599	3.79	23.66	1.15	541223	8.08374202	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
UPCUniverse Pharmaceuticals Inc	US$ 2.92 (178.10%)	91.51M
LIFWMSP Recovery Inc	US$ 3.27 (105.66%)	19.69M
GXAIGaxos ai Inc	US$ 2.51 (76.76%)	139.55M
SMXSMX Security Matters Public Company	US$ 0.5098 (71.42%)	429.82M
SBETSharpLink Gaming Inc	US$ 0.8896 (69.77%)	25.71M
ORISOriental Rise Holdings Ltd	US$ 3.68 (-93.43%)	24.02M
LICNLichen China Limited	US$ 0.4662 (-78.01%)	174.8M
MYNAMynaric AG	US$ 0.5001 (-64.53%)	3.25M
CEROCERo Therapeutics Holdings Inc	US$ 0.1157 (-39.58%)	32.65M
BJDXBluejay Diagnostics Inc	US$ 4.16 (-32.90%)	409.24k
SMXSMX Security Matters Public Company	US$ 0.5098 (71.42%)	429.82M
SOUNSoundHound AI Inc	US$ 14.7518 (10.67%)	196.43M
LICNLichen China Limited	US$ 0.4662 (-78.01%)	174.8M
NVDANVIDIA Corporation	US$ 142.275 (-1.92%)	144.87M
SVMHSRIVARU Holding Ltd	US$ 0.03005 (-14.14%)	143.84M